• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析胰腺导管腺癌免疫微环境中各成分和特征的预后意义。

Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.

机构信息

Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.

出版信息

Front Immunol. 2021 Mar 10;12:648917. doi: 10.3389/fimmu.2021.648917. eCollection 2021.

DOI:10.3389/fimmu.2021.648917
PMID:33777046
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7987951/
Abstract

The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor microenvironment, such as immune checkpoint inhibitors, have shown promising efficacy for some tumors, few of them significantly prolong the survival of patients with PDAC due to insufficient knowledge on the tumor microenvironment. A single-cell RNA sequencing (scRNA-seq) dataset and seven PDAC cohorts with complete clinical and bulk sequencing data were collected for bioinformatics analysis. The relative proportions of each cell type were estimated using the gene set variation analysis (GSVA) algorithm based on the signatures identified by scRNA-seq or previous literature. A meta-analysis of 883 PDAC patients showed that neutrophils are associated with worse overall survival (OS) for PDAC, while CD8+ T cells, CD4+ T cells, and B cells are related to prolonged OS for PDAC, with marginal statistical significance. Seventeen cell categories were identified by clustering analysis based on single-cell sequencing. Among them, CD8+ T cells and NKT cells were universally exhausted by expressing exhaustion-associated molecular markers. Interestingly, signatures of CD8+ T cells and NKT cells predicted prolonged OS for PDAC only in the presence of "targets" for pyroptosis and ferroptosis induction. Moreover, a specific state of T cells with overexpression of ribosome-related proteins was associated with a good prognosis. In addition, the hematopoietic stem cell (HSC)-like signature predicted prolonged OS in PDAC. Weighted gene co-expression network analysis identified 5 hub genes whose downregulation may mediate the observed survival benefits of the HSC-like signature. Moreover, trajectory analysis revealed that myeloid cells evolutionarily consisted of 7 states, and antigen-presenting molecules and complement-associated genes were lost along the pseudotime flow. Consensus clustering based on the differentially expressed genes between two states harboring the longest pseudotime span identified two PDAC groups with prognostic differences, and more infiltrated immune cells and activated immune signatures may account for the survival benefits. This study systematically investigated the prognostic implications of the components of the PDAC tumor microenvironment by integrating single-cell sequencing and bulk sequencing, and future studies are expected to develop novel targeted agents for PDAC treatment.

摘要

胰腺导管腺癌 (PDAC) 的治疗方法有限且效果不佳。尽管许多针对肿瘤微环境的新型药物,如免疫检查点抑制剂,在某些肿瘤中显示出有希望的疗效,但由于对肿瘤微环境的了解不足,它们很少能显著延长 PDAC 患者的生存时间。本研究收集了一个单细胞 RNA 测序 (scRNA-seq) 数据集和七个具有完整临床和批量测序数据的 PDAC 队列,进行生物信息学分析。使用基于 scRNA-seq 或先前文献中鉴定的特征的基因集变异分析 (GSVA) 算法估计每种细胞类型的相对比例。对 883 名 PDAC 患者的荟萃分析表明,中性粒细胞与 PDAC 的总生存期 (OS) 较差相关,而 CD8+ T 细胞、CD4+ T 细胞和 B 细胞与 PDAC 的 OS 延长相关,具有边缘统计学意义。基于单细胞测序的聚类分析确定了 17 个细胞类别。其中,CD8+ T 细胞和 NKT 细胞普遍通过表达衰竭相关分子标志物而衰竭。有趣的是,只有在存在细胞焦亡和铁死亡诱导的“靶点”的情况下,CD8+ T 细胞和 NKT 细胞的特征才预示着 PDAC 的 OS 延长。此外,过度表达核糖体相关蛋白的 T 细胞的特定状态与良好的预后相关。此外,造血干细胞 (HSC) 样特征预测 PDAC 的 OS 延长。加权基因共表达网络分析确定了 5 个下调可能介导 HSC 样特征观察到的生存获益的枢纽基因。此外,轨迹分析显示,髓样细胞沿伪时间流进化为 7 个状态,抗原呈递分子和补体相关基因丢失。基于两个具有最长伪时间跨度的状态之间差异表达基因的共识聚类,确定了两个具有预后差异的 PDAC 组,更多浸润的免疫细胞和激活的免疫特征可能解释了生存获益。本研究通过整合单细胞测序和批量测序,系统研究了 PDAC 肿瘤微环境成分的预后意义,未来的研究有望为 PDAC 的治疗开发新的靶向药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/9d7378877f19/fimmu-12-648917-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/e99758fd7b00/fimmu-12-648917-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/07bad9bd8dcc/fimmu-12-648917-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/3614d0387d05/fimmu-12-648917-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/ba200db34762/fimmu-12-648917-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/e1c892fc3395/fimmu-12-648917-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/bd2fbdad15e5/fimmu-12-648917-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/9d7378877f19/fimmu-12-648917-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/e99758fd7b00/fimmu-12-648917-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/07bad9bd8dcc/fimmu-12-648917-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/3614d0387d05/fimmu-12-648917-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/ba200db34762/fimmu-12-648917-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/e1c892fc3395/fimmu-12-648917-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/bd2fbdad15e5/fimmu-12-648917-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a0e5/7987951/9d7378877f19/fimmu-12-648917-g0007.jpg

相似文献

1
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma.解析胰腺导管腺癌免疫微环境中各成分和特征的预后意义。
Front Immunol. 2021 Mar 10;12:648917. doi: 10.3389/fimmu.2021.648917. eCollection 2021.
2
Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.单细胞 RNA 测序揭示了抗 CD47 靶向治疗诱导的胰腺癌肿瘤浸润免疫细胞的区室重排。
J Hematol Oncol. 2019 Nov 27;12(1):124. doi: 10.1186/s13045-019-0822-6.
3
Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.单细胞 RNA 测序揭示了胰腺导管腺癌恶性进展过程中肿瘤微环境的动态变化。
EBioMedicine. 2021 Apr;66:103315. doi: 10.1016/j.ebiom.2021.103315. Epub 2021 Apr 2.
4
Single-cell transcriptome analysis of tumor and stromal compartments of pancreatic ductal adenocarcinoma primary tumors and metastatic lesions.胰腺导管腺癌原发肿瘤和转移病灶肿瘤和基质区室的单细胞转录组分析。
Genome Med. 2020 Sep 29;12(1):80. doi: 10.1186/s13073-020-00776-9.
5
Single-cell transcriptome reveals the heterogeneity of malignant ductal cells and the prognostic value of REG4 and SPINK1 in primary pancreatic ductal adenocarcinoma.单细胞转录组揭示了原发性胰腺导管腺癌中恶性导管细胞的异质性和 REG4 和 SPINK1 的预后价值。
PeerJ. 2024 May 28;12:e17350. doi: 10.7717/peerj.17350. eCollection 2024.
6
Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas.基于 HIF-1 信号的预后分层评估胰腺导管腺癌的缺氧状态和免疫浸润。
Front Immunol. 2021 Dec 3;12:790661. doi: 10.3389/fimmu.2021.790661. eCollection 2021.
7
Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response.系统分析胰腺导管腺癌中的可变剪接全景揭示与肿瘤发生和免疫反应相关的调控网络。
Med Sci Monit. 2020 Jul 24;26:e925733. doi: 10.12659/MSM.925733.
8
Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma.单细胞和 bulk RNA 测序相结合,揭示 NK 细胞标志物基因在胰腺导管腺癌中的预后和免疫状态。
Sci Rep. 2024 Jul 1;14(1):15037. doi: 10.1038/s41598-024-65917-1.
9
Unraveling pancreatic ductal adenocarcinoma immune prognostic signature through a naive B cell gene set.通过幼稚 B 细胞基因集解析胰腺导管腺癌免疫预后特征。
Cancer Lett. 2024 Jul 10;594:216981. doi: 10.1016/j.canlet.2024.216981. Epub 2024 May 23.
10
Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.胰腺导管腺癌中的浸润免疫细胞和基因突变。
Br J Surg. 2016 Aug;103(9):1189-99. doi: 10.1002/bjs.10187. Epub 2016 Jun 3.

引用本文的文献

1
Multi-omics analysis and validation of autophagy-related diagnostic biomarker in osteoarthritis.骨关节炎中自噬相关诊断生物标志物的多组学分析与验证
Ann Med. 2025 Dec;57(1):2548045. doi: 10.1080/07853890.2025.2548045. Epub 2025 Aug 19.
2
APOBEC3C-Mediated NF-κB Activation Promotes Malignant Progression of Gliomas.载脂蛋白B mRNA编辑酶催化多肽样3C介导的核因子κB激活促进胶质瘤的恶性进展。
Immun Inflamm Dis. 2025 Jul;13(7):e70224. doi: 10.1002/iid3.70224.
3
Multifaceted function of B cells in tumorigenesis.B细胞在肿瘤发生中的多方面功能。

本文引用的文献

1
Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis.核糖体靶向抗生素通过阻断线粒体蛋白质合成来抑制 T 细胞效应功能并改善自身免疫。
Immunity. 2021 Jan 12;54(1):68-83.e6. doi: 10.1016/j.immuni.2020.11.001. Epub 2020 Nov 24.
2
Single-cell transcriptomes of pancreatic preinvasive lesions and cancer reveal acinar metaplastic cells' heterogeneity.胰腺癌前病变和癌症的单细胞转录组揭示了腺泡细胞化生细胞的异质性。
Nat Commun. 2020 Sep 9;11(1):4516. doi: 10.1038/s41467-020-18207-z.
3
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
Front Med. 2025 Apr;19(2):297-317. doi: 10.1007/s11684-025-1127-5. Epub 2025 Mar 22.
4
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy.新型来源的 CAR 产品:癌症免疫治疗突破的新途径。
Front Immunol. 2024 Apr 11;15:1378739. doi: 10.3389/fimmu.2024.1378739. eCollection 2024.
5
Comprehensive analysis of CYBB as a prognostic marker and therapeutic target in glioma: A bioinformatics approach.CYBB作为胶质瘤预后标志物和治疗靶点的综合分析:一种生物信息学方法
Heliyon. 2024 Apr 14;10(8):e29549. doi: 10.1016/j.heliyon.2024.e29549. eCollection 2024 Apr 30.
6
Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer.单细胞测序在胰腺癌临床诊断与治疗中的进展
Front Med (Lausanne). 2023 Aug 31;10:1213136. doi: 10.3389/fmed.2023.1213136. eCollection 2023.
7
Heterogeneous tumor microenvironment in pancreatic ductal adenocarcinoma: An emerging role of single-cell analysis.胰腺导管腺癌中的异质性肿瘤微环境:单细胞分析的新作用
Cancer Med. 2023 Sep;12(17):18020-18031. doi: 10.1002/cam4.6407. Epub 2023 Aug 3.
8
Immunotherapy and Pancreatic Cancer: A Lost Challenge?免疫疗法与胰腺癌:一项难以攻克的挑战?
Life (Basel). 2023 Jun 30;13(7):1482. doi: 10.3390/life13071482.
9
Safety and Clinical Response to Combined Immunotherapy with Autologous iNKT Cells and PD-1CD8 T Cells in Patients Failing First-line Chemotherapy in Stage IV Pancreatic Cancer.在接受一线化疗失败的 IV 期胰腺癌患者中,联合使用自体 iNKT 细胞和 PD-1CD8 T 细胞的免疫治疗的安全性和临床反应。
Cancer Res Commun. 2023 Jun 7;3(6):991-1003. doi: 10.1158/2767-9764.CRC-23-0137. eCollection 2023 Jun.
10
Identification and validation of novel signature associated with hepatocellular carcinoma prognosis using Single-cell and WGCNA analysis.基于单细胞测序和 WGCNA 分析鉴定与肝癌预后相关的新型标志物并验证。
Int J Med Sci. 2023 May 11;20(7):870-887. doi: 10.7150/ijms.79274. eCollection 2023.
铁死亡、坏死性凋亡和细胞焦亡在抗肿瘤免疫中的作用。
J Hematol Oncol. 2020 Aug 10;13(1):110. doi: 10.1186/s13045-020-00946-7.
4
Dynamics in protein translation sustaining T cell preparedness.蛋白质翻译中的动态变化维持 T 细胞的预备状态。
Nat Immunol. 2020 Aug;21(8):927-937. doi: 10.1038/s41590-020-0714-5. Epub 2020 Jul 6.
5
Killer cells add fire to fuel immunotherapy.杀伤细胞为免疫疗法“火上浇油”。
Science. 2020 May 29;368(6494):943-944. doi: 10.1126/science.abc2502.
6
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
7
Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.干性指数相关特征在原发性低级别胶质瘤中的预后价值
Front Genet. 2020 May 5;11:441. doi: 10.3389/fgene.2020.00441. eCollection 2020.
8
Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells.细胞毒性淋巴细胞中的颗粒酶 A 裂解 GSDMB 以在靶细胞中引发细胞焦亡。
Science. 2020 May 29;368(6494). doi: 10.1126/science.aaz7548. Epub 2020 Apr 16.
9
Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer.从 TCGA 数据库挖掘肿瘤突变负荷及其在膀胱癌中的临床意义。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20194337.
10
Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.胰腺导管腺癌的免疫微环境与免疫治疗前景
Chronic Dis Transl Med. 2020 Feb 11;6(1):6-17. doi: 10.1016/j.cdtm.2020.01.002. eCollection 2020 Mar.